124 related articles for article (PubMed ID: 12780494)
1. Abnormal Pap test results and the rurality factor.
Dietsch E; Gibb H; Francis K
Aust J Rural Health; 2003 Apr; 11(2):50-6. PubMed ID: 12780494
[TBL] [Abstract][Full Text] [Related]
2. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
Gram IT; Macaluso M; Stalsberg H
Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of abnormal Pap smears in rural family practice.
Miller KS; Yunger J; Single N; Kunz J
J Rural Health; 1996; 12(1):33-8. PubMed ID: 10157081
[TBL] [Abstract][Full Text] [Related]
4. The Italian experience of a Pap test and speculoscopy based screening programme.
Boselli F; De Martis S; Rivasi F; Toni A; Abbiati R; Chiossi G
J Med Screen; 2000; 7(3):160-2. PubMed ID: 11126166
[TBL] [Abstract][Full Text] [Related]
5. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
6. Cervical neoplasia in pap smears: risk of cervical intra-epithelial neoplasia (CIN) after negative or no prior smears in a population without a mass screening programme.
Forsmo S; Jacobsen BK; Stalsberg H
Int J Epidemiol; 1996 Feb; 25(1):53-8. PubMed ID: 8666505
[TBL] [Abstract][Full Text] [Related]
7. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Sherman ME; Lorincz AT; Scott DR; Wacholder S; Castle PE; Glass AG; Mielzynska-Lohnas I; Rush BB; Schiffman M
J Natl Cancer Inst; 2003 Jan; 95(1):46-52. PubMed ID: 12509400
[TBL] [Abstract][Full Text] [Related]
8. The Incidence and Clinical Significance of Atypical Glandular Cells of Undetermined Significance on Cervical Pap Smears.
Al-Rayyan E; Rashed M; Maaita M; Qudah S; Taso O; Haddadin W
Gulf J Oncolog; 2019 May; 1(30):52-56. PubMed ID: 31242982
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia.
Hosseini MS; Khosravi D; Farzaneh F; Ebrahimi A; Arab M; Ashraf Ganjoie T; Jamdar F; Moridi A; Chehrazi M
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3071-3075. PubMed ID: 30485943
[TBL] [Abstract][Full Text] [Related]
10. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
[TBL] [Abstract][Full Text] [Related]
11. CIN 2/3 and cervical cancer after an ASCUS pap smear. A 7-year, prospective study of the Norwegian population-based, coordinated screening program.
Nygård JF; Sauer T; Skjeldestad FE; Skare GB; Thoresen SØ
Acta Cytol; 2003; 47(6):991-1000. PubMed ID: 14674068
[TBL] [Abstract][Full Text] [Related]
12. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
[TBL] [Abstract][Full Text] [Related]
13. Screening histories of women with CIN 2/3 compared with women diagnosed with invasive cervical cancer: a retrospective analysis of the Norwegian Coordinated Cervical Cancer Screening Program.
Nygård JF; Nygård M; Skare GB; Thoresen SØ
Cancer Causes Control; 2005 May; 16(4):463-74. PubMed ID: 15953989
[TBL] [Abstract][Full Text] [Related]
14. Influence of cytology development on frequency of pre-cancerous lesions and cervical cancer in east Croatia, 1978-2001.
Milojković M; Pajtler M
Coll Antropol; 2004 Jun; 28(1):293-300. PubMed ID: 15636086
[TBL] [Abstract][Full Text] [Related]
15. [Estimated results of prophylactic physical examinations detecting cervical cancer in Center of Oncology in Bydgoszcz in years 2001-2003].
Mierzwa T; Grabiec M; Walentowicz M
Ginekol Pol; 2005 Sep; 76(9):693-8. PubMed ID: 16417080
[TBL] [Abstract][Full Text] [Related]
16. Risk of high-grade cervical intraepithelial neoplasia among young women with abnormal screening cytology.
Massad SL; Markwell S; Cejtin HE; Collins Y
J Low Genit Tract Dis; 2005 Oct; 9(4):225-9. PubMed ID: 16205193
[TBL] [Abstract][Full Text] [Related]
17. [Following-up females having an abnormal Pap smear in Colombia].
Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
19. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of cytology-based cervical cancer screening in rural Cameroon.
Robyr R; Nazeer S; Vassilakos P; Matute JC; Sando Z; Halle G; Mbakop A; Campana A
Acta Cytol; 2002; 46(6):1110-6. PubMed ID: 12462091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
